COSCIENS Biopharma Financials
| CSCI Stock | 3.13 0.04 1.29% |
Operating Margin (1.61) | Short Ratio 1.64 | Return On Equity (0.66) |
Investors should never underestimate COSCIENS Biopharma's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor COSCIENS Biopharma's cash flow, debt, and profitability to make informed and accurate decisions about investing in COSCIENS Biopharma.
Net Income |
|
COSCIENS | Select Account or Indicator |
Understanding current and past COSCIENS Biopharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of COSCIENS Biopharma's financial statements are interrelated, with each one affecting the others. For example, an increase in COSCIENS Biopharma's assets may result in an increase in income on the income statement.
COSCIENS Biopharma Stock Summary
COSCIENS Biopharma competes with MGIC Investment, Willamette Valley, SNDL, Oatly Group, and Vodka Brands. COSCIENS Biopharma is entity of United States. It is traded as Stock on NASDAQ exchange.| Foreign Associate | Canada |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 007975402 007975303 007975501 007975600 22112H101 007975204 007975105 |
| Older Symbol | AEZS |
| Location | Quebec; Canada |
| Business Address | 222 Bay Street, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.cosciensbio.com |
COSCIENS Biopharma Key Financial Ratios
| Revenue | 7.26 M | ||||
| Net Income | (3.55 M) | ||||
| Total Asset | 31.45 M | ||||
| Retained Earnings | 6.17 M |
COSCIENS Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining COSCIENS Biopharma's current stock value. Our valuation model uses many indicators to compare COSCIENS Biopharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across COSCIENS Biopharma competition to find correlations between indicators driving COSCIENS Biopharma's intrinsic value. More Info.COSCIENS Biopharma is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the COSCIENS Biopharma's earnings, one of the primary drivers of an investment's value.COSCIENS Biopharma Systematic Risk
COSCIENS Biopharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. COSCIENS Biopharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on COSCIENS Biopharma correlated with the market. If Beta is less than 0 COSCIENS Biopharma generally moves in the opposite direction as compared to the market. If COSCIENS Biopharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one COSCIENS Biopharma is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of COSCIENS Biopharma is generally in the same direction as the market. If Beta > 1 COSCIENS Biopharma moves generally in the same direction as, but more than the movement of the benchmark.
About COSCIENS Biopharma Financials
What exactly are COSCIENS Biopharma Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include COSCIENS Biopharma's income statement, its balance sheet, and the statement of cash flows. Potential COSCIENS Biopharma investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although COSCIENS Biopharma investors may use each financial statement separately, they are all related. The changes in COSCIENS Biopharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on COSCIENS Biopharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.COSCIENS Biopharma November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of COSCIENS Biopharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of COSCIENS Biopharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of COSCIENS Biopharma based on widely used predictive technical indicators. In general, we focus on analyzing COSCIENS Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build COSCIENS Biopharma's daily price indicators and compare them against related drivers.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 16.83 | |||
| Value At Risk | (5.57) | |||
| Potential Upside | 5.34 |
Complementary Tools for COSCIENS Stock analysis
When running COSCIENS Biopharma's price analysis, check to measure COSCIENS Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy COSCIENS Biopharma is operating at the current time. Most of COSCIENS Biopharma's value examination focuses on studying past and present price action to predict the probability of COSCIENS Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move COSCIENS Biopharma's price. Additionally, you may evaluate how the addition of COSCIENS Biopharma to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |